Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease

Vicente E. Torres, Xiaofang Wang, Qi Qian, Stefan Somlo, Peter C. Harris, Vincent H. Gattone

Research output: Contribution to journalArticle

329 Scopus citations

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a leading cause of end-stage renal disease. The vasopressin V2 receptor (VPV2R) antagonist OPC31260 has been effective in two animal models of PKD with pathologies that are probably related. Here we show, in a mouse model of ADPKD (Pkd2 -/tms1m), a similar cellular phenotype and response to OPC31260 treatment, with reduction of renal cyclic AMP (cAMP) levels, prevention of renal enlargement, marked inhibition of cystogenesis and protection of renal function.

Original languageEnglish (US)
Pages (from-to)363-364
Number of pages2
JournalNature Medicine
Volume10
Issue number4
DOIs
StatePublished - Apr 1 2004

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease'. Together they form a unique fingerprint.

  • Cite this